Report Categories
View AllRecent Articles
View All
Which Stocks Like Prestige PBH Marginal Gain 20260420
JPMorgan Chase Co JPM Persian Gulf Supply Disruptions to Drive Sustained Oil Price Upside Weigh on Asian Economic Growth
Genelux Corporation GNLX Sector Trends Genelux Corporation misses EPS estimates by 123
ALUB AlussaEnergy latest quarterly earnings release withholds core financial metrics amid ongoing SPAC merger negotiations
What is influencing demand for AirSculpt AIRS stock Q4 2025 Earnings Beat Estimates
CRNC Cerence reports wide Q1 2026 EPS miss even as shares rise more than 6 percent on positive investor sentiment
ALBT Avalon Globo climbs 336 percent following the release of its Q3 2023 earnings results
Is Helport AI HPAIW the most overlooked stock right now 2478 20260506
Core Inflation Hits 32 in March as Q1 GDP Growth Disappoints Amid Geopolitical Tensions
ICICI Prudential Mutual Fund Increases Stake in PI Industries to Over 7 Details
US AI Expansion in Asia Gains Momentum Following TrumpXi Summit
SP 500 Edges Higher as Consumer Plays Offset Energy and Tech Drags
Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes Under Incoming Chair Warsh
Automated Garment Machines Could Reshape Global Apparel Supply Chains
CONMED Q1 2026 Earnings EPS Surpasses Expectations as Profitability Improves
Deckers Outdoor DECK Q1 2026 Earnings Ugg and Hoka Drive DoubleDigit EPS Beat Revenue Details Withheld
MediaAlpha MAX Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain
SPS Commerce Q1 2026 Earnings EPS Surprises to the Upside as Operating Discipline Supports Bottom Line
QNRX Q1 2026 Earnings Beats EPS Estimates Despite No Revenue Stock Declines 062
FBRX Q1 2026 Earnings WiderthanExpected Loss Reflects PreRevenue Biotech Reality
Krispy Kreme DNUT Slips 18 to 327 as Stock Tests Key Support Zone
UTStarcom Holdings UTSI Surges 575 as Shares Test Key Resistance at 298
Vistagen Therapeutics VTGN Slides 155 as Traders Eye Critical Support at 061
Indonesia Energy Corporation INDO Slides 241 as Shares Approach Critical Support Near 270
Kiora Pharmaceuticals KPRX Holds Steady Near Support as Biotech Sector Faces Headwinds